30-Country IVD Market Atlas (US, China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, Turkey and 20 Other Countries)

    Published: February 27, 2023 | Price: $7,500.00 – $15,000.00

    One Report Covering 30 Countries Sizing for 19 Important IVD Market Segments Segments Estimated for Each Country Forecasts to 2027 for Each Segment Updated Quarterly (4 updates annually) to Reflect Market Changes Over 2800 Data Points Over two decades of publishing in vitro diagnostic market research, Kalorama Information has heard from customers: IVD is a global industry, growth is global and our customers want more geographic coverage.  Regional coverage is useful for some activities, but regions don't tell the whole...
    The Market and Future Potential for Molecular Point of Care (mPOC), 2023

    Published: February 7, 2023 | Price: $5,000.00 – $10,000.00

    This report is an essential tool for understanding the size and growth opportunity in molecular POC.  Molecular point of care (mPOC) has gone from novel trend to significant contributor to the market.  The instruments sold by Abbott, BioMérieux, Cepheid and increasingly, a host of other companies, are a significant contributor to the IVD POC market.  Knowing these markets is essential to knowing the opportunity in point of care testing and microbiology IVD. Since 2013, Kalorama has been producing a dedicated...
    World Market for Cancer Diagnostics

    Published: November 22, 2021 | Price: $9,000.00 – $12,000.00

    Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis, therapy selection, therapy monitoring and early detection of cancer recurrence.  The World Market for Cancer Diagnostics, as well as relevant industry merger data provided by Kalorama Information, provides authoritative and complete analysis of the cancer testing industry, with expert market sizing and opportunity assessment. Segment markets for cancer testing are comprehensively covered in Kalorama Information’s World Market for Cancer Diagnostics. ...
    Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities

    Published: June 17, 2020 | Price: $6,000.00 – $12,000.00

    Kalorama Information's report provides a comprehensive market analysis and business planning tool for the market for tests that are aligned with a pharmaceutical treatment.  Especially in oncology, companion diagnostics are rising to the forefront of pharmaceutical development and treatment. Companion diagnostics increase the probability of clinical success by identifying patients with the presence of biomarkers or disease-specific therapeutic targets that can dramatically improve outcomes.   Companion diagnostics can also decrease costs by identifying the patient population that will most likely benefit...